191 related articles for article (PubMed ID: 36765502)
21. Hemolytic disease of the newborn due to anti-Jra from a Chinese mother with one novel and one classic heterozygous mutation.
Xiao J; Yang Q; Gao S; Song H; Zhao F; Guo Z; Zhang Y; Zhu Z; Ye L; Xiang D
Transfus Med; 2023 Aug; 33(4):297-305. PubMed ID: 36971189
[TBL] [Abstract][Full Text] [Related]
22. A Rare Case of Hemolytic Disease of the Fetus and Newborn Caused by Anti-s Antibody in a Chinese Patient.
Liyan Y; Yongmei J; Jing F
Clin Lab; 2023 Apr; 69(4):. PubMed ID: 37057931
[TBL] [Abstract][Full Text] [Related]
23. Clinical Significance of Rare Maternal Anti Jk
Mittal K; Sood T; Bansal N; Bedi RK; Kaur P; Kaur G
Indian J Hematol Blood Transfus; 2016 Dec; 32(4):497-499. PubMed ID: 27812263
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of Screening Results in 501 Newborns with Hemolytic Disease].
Ma X; Chen FZ; Hong Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):192-196. PubMed ID: 30738469
[TBL] [Abstract][Full Text] [Related]
25. Hemolytic disease of the fetus and newborn mediated by anti-Di
Jacobs JW; Abels E; Binns TC; Tormey CA; Sostin N
Immunohematology; 2023 Apr; 39(1):32-34. PubMed ID: 37017601
[TBL] [Abstract][Full Text] [Related]
26. [The Correlation Analysis between the Titer of IgG Anti-A/B Erythrocyte Antibody In Vivo of the Neonate and the Severity of Hemolytic Disease of Newborn].
Song J; Yang T; Zhou XF; Yang YZ; Peng DL; Zhang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):547-551. PubMed ID: 35395995
[TBL] [Abstract][Full Text] [Related]
27. Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes.
de Winter DP; Kaminski A; Tjoa ML; Oepkes D; Lopriore E
BMC Pregnancy Childbirth; 2023 Oct; 23(1):738. PubMed ID: 37853331
[TBL] [Abstract][Full Text] [Related]
28. Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion.
Jain A; Malhotra S; Marwaha N; Kumar P; Sharma RR
Asian J Transfus Sci; 2018; 12(2):176-179. PubMed ID: 30692807
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of direct antiglobulin test positivity at tertiary academic hospital over 10 years.
Rahmati A; Farhat AS; Boroumand-Noughabi S; Soleymani F; Keramati M
Transfus Apher Sci; 2022 Jun; 61(3):103358. PubMed ID: 35074271
[TBL] [Abstract][Full Text] [Related]
30. Haemolytic disease of fetus and newborn caused by ABO antibodies in a cisAB offspring.
Deng ZH; Seltsam A; Ye YW; Yu Q; Li Q; Su YQ; Liang YL; Zang H
Transfus Apher Sci; 2008 Oct; 39(2):123-8. PubMed ID: 18793871
[TBL] [Abstract][Full Text] [Related]
31. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
Blyth U; Larsson M; Baird A; Waring G; Athiraman N
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
[TBL] [Abstract][Full Text] [Related]
32. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
Delaney M; Matthews DC
Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
[TBL] [Abstract][Full Text] [Related]
33. Severe hemolytic disease of the fetus and newborn due to anti-E and anti-Jka.
Mandal S; Malhotra S; Negi G; Tiwari A; Mitra S; Basu S; Singh P
Immunohematology; 2020 Jun; 36(2):60-63. PubMed ID: 32667819
[TBL] [Abstract][Full Text] [Related]
34. Hemolytic Disease of the Fetus and Newborn Caused by Anti-Group A IgG From a Group B Mother.
Wang R; Li Y; Tong Y; Su N
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e785-e787. PubMed ID: 33003144
[TBL] [Abstract][Full Text] [Related]
35. Hemolytic Disease of the Fetus and Newborn Due to Anti-Gonzales Antibody.
Fives KR; Chism DA; Beetz B; Elkins I; Butala M
Cureus; 2023 Mar; 15(3):e36860. PubMed ID: 37123720
[TBL] [Abstract][Full Text] [Related]
36. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
[TBL] [Abstract][Full Text] [Related]
37. The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers.
Talwar M; Jain A; Sharma RR; Kumar P; Saha SC; Singh L
Vox Sang; 2022 Sep; 117(9):1112-1120. PubMed ID: 35667836
[TBL] [Abstract][Full Text] [Related]
38. Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal-foetal incompatibility: A retrospective cohort study.
Franchinard L; Maisonneuve E; Friszer S; Toly Ndour C; Huguet-Jacquot S; Maurice P; Mailloux A; Cortey A; Jouannic JM
Vox Sang; 2022 Apr; 117(4):570-579. PubMed ID: 34743337
[TBL] [Abstract][Full Text] [Related]
39. Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kp(b).
Bleile MJ; Rijhsinghani A; Dwyre DM; Raife TJ
Transfus Apher Sci; 2010 Dec; 43(3):281-283. PubMed ID: 20951648
[TBL] [Abstract][Full Text] [Related]
40. Cell-Free DNA and Next-Generation Sequencing for Prenatal Diagnosis.
Rieneck K
Methods Mol Biol; 2024; 2753():583-609. PubMed ID: 38285369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
